Results 201 to 210 of about 414,333 (305)

Coronavirus disease 2019 (COVID-19) for global faith and community leaders [Spanish]

open access: yes
Coronavirus disease 2019 (COVID-19) for global faith and community leaders [Spanish]cdc.gov/coronavirus-eswww.cdc.gov/coronavirus/2019-ncov/global-covid-19Publication date from document properties.COVID-19-global-faith-community-leaders_spanish ...

core  

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial

open access: yesAddiction, EarlyView.
Abstract Background and Aims Psilocybin has emerged as a potential treatment for alcohol use disorder (AUD), but early efficacy data are inconsistent. Depression following alcohol detoxification significantly increases the risk of relapse. This pilot study aimed to evaluate the feasibility, acceptability, and preliminary efficacy of psilocybin‐assisted
Amandine Luquiens   +7 more
wiley   +1 more source

Coronavirus disease 2019-associated mucormycosis and cytomegalovirus infection: a case report. [PDF]

open access: yesJ Med Case Rep
Muqtadir J   +5 more
europepmc   +1 more source

Estimating thresholds for risk of cannabis use disorder using standard delta‐9‐tetrahydrocannabinol (THC) units

open access: yesAddiction, EarlyView.
Abstract Background and aims Lower risk guidelines for safer levels of cannabis use could help to reduce the health burden posed by cannabis use disorder (CUD). We aimed to estimate risk thresholds for CUD based on delta‐9‐tetrahydrocannabinol (THC) consumption using standard THC units (1 unit = 5 mg THC).
Rachel Lees Thorne   +9 more
wiley   +1 more source

Acute tubulointerstitial nephritis following a coronavirus disease 2019 vaccine booster dose: a pediatric case report. [PDF]

open access: yesCEN Case Rep
Sakaguchi H   +10 more
europepmc   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

open access: yesAddiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark   +8 more
wiley   +1 more source

Declining trends in adolescent alcohol consumption and related harms: No room for complacency (an empirical reply to Vieira et al. 2025)

open access: yesAddiction, EarlyView.
Abstract Vieira et al. report that alcohol‐related harms among adolescents have generally declined in high‐income countries where youth drinking has decreased, but several methodological choices complicate this conclusion. By performing reproducibility analyses on Vieira et al.'s raw data, we show that their findings are more nuanced and complex ...
Charlotte R. Pennington   +4 more
wiley   +1 more source

Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019. [PDF]

open access: yesYonago Acta Med
Nagamizu K   +11 more
europepmc   +1 more source

Coronavirus disease 2019 (COVID-19) for global faith and community leaders [French]

open access: yes
Coronavirus disease 2019 (COVID-19) for global faith and community leaders [French]cdc.gov/coronaviruswww.cdc.gov/coronavirus/2019-ncov/global-covid-19Publication date from document properties.COVID-19-global-faith-community-leaders_french ...

core  

Home - About - Disclaimer - Privacy